On August 26, Amgen (AMGN) announced the purchase of leading immunology drug Otezla from Celgene (CELG) for a cash consideration of $13.4 billion.
https://www.investing.com/news/economy/top-china-trade-negotiator-calls-for-calm-as-trump-tensions-grow-1963126
Market Realist
This site is not involved in the creation of this post.
